# Heidelberg University Hospital / NCT / DKFZ

Source: https://onco.cc/institutions/heidelberg-nct/  
OnCo record `heidelberg-nct` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Heidelberg is Germany's cancer research capital, home to the DKFZ (largest cancer research institute in Germany) and the NCT, and the birthplace of FAPI PET and the brain tumour methylation classifier.

## Summary

Heidelberg University Hospital, with the National Center for Tumor Diseases and the German Cancer Research Center (DKFZ), is Germany's cancer research capital and ranks eighteenth in the Newsweek/Statista oncology list. Its record includes the FAPI PET tracers from Haberkorn, Giesel and Kratochwil, the first-in-human actinium-225 PSMA therapy, the Heidelberg Ion-Beam Therapy Center for carbon ions, the DKFZ brain tumour methylation classifier from Pfister and von Deimling, and the MASTER precision oncology programme, with Stefan Fröhling among its leaders. OnCo links it to FAP and PSMA as targets, to SOFIE Biosciences, to the first vaccine trial against shared neoantigens of mismatch-repair-deficient cancers, and to ideas for a university cyclotron network and core-funded radiotherapy trials. Turning tracers into approved therapies at scale is the open problem. The DKFZ has its own page.

## Fields

- Kind: Institution
- Last checked: 2026-09-04
- City: Heidelberg, DE
- Type: cancer-center
- Website: https://www.nct-heidelberg.de

## Sources

- Official website: https://www.nct-heidelberg.de
- PTCOG: particle therapy facilities in operation: https://www.ptcog.site/index.php/facilities-in-operation-public

## Connected records

- technologies: [Carbon-ion synchrotrons and facilities](https://onco.cc/technologies/carbon-ion-synchrotrons/), [Carbon-ion therapy](https://onco.cc/technologies/carbon-ion/), [DNA methylation profiling](https://onco.cc/technologies/methylation-profiling/), [FAPI PET](https://onco.cc/technologies/fapi-pet/), [MR-guided adaptive radiotherapy](https://onco.cc/technologies/mr-linac/), [Proton therapy](https://onco.cc/technologies/proton-therapy/), [Proton therapy machines: cyclotrons, synchrotrons and single-room systems](https://onco.cc/technologies/proton-therapy-systems/), [Targeted alpha therapy](https://onco.cc/technologies/targeted-alpha-therapy/), [TomoTherapy and Radixact (helical radiotherapy)](https://onco.cc/technologies/tomotherapy/)
- targets: [FAP](https://onco.cc/targets/fap/), [PSMA](https://onco.cc/targets/psma/)
- people: [Andreas von Deimling](https://onco.cc/people/andreas-von-deimling/), [Clemens Kratochwil](https://onco.cc/people/clemens-kratochwil/), [Frederik Giesel](https://onco.cc/people/frederik-giesel/), [Jürgen Debus](https://onco.cc/people/juergen-debus/), [Stefan Fröhling](https://onco.cc/people/stefan-froehling/), [Stefan Pfister](https://onco.cc/people/stefan-pfister/), [Uwe Haberkorn](https://onco.cc/people/uwe-haberkorn/)
- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/), [Neuroendocrine tumours](https://onco.cc/cancers/neuroendocrine/)
- companies: [SOFIE Biosciences](https://onco.cc/companies/sofie-biosciences/), [ViewRay (MRIdian)](https://onco.cc/companies/viewray/)
- institutions: [Deutsche Krebsgesellschaft](https://onco.cc/institutions/deutsche-krebsgesellschaft/), [Deutsche Krebshilfe](https://onco.cc/institutions/deutsche-krebshilfe/), [Deutsches Netzwerk für Personalisierte Medizin](https://onco.cc/institutions/dnpm/), [European Association of Nuclear Medicine](https://onco.cc/institutions/eanm/), [German Cancer Research Center (DKFZ)](https://onco.cc/institutions/dkfz/), [NCT/UCC Dresden, University Hospital Carl Gustav Carus](https://onco.cc/institutions/nct-dresden/), [Paul-Ehrlich-Institut](https://onco.cc/institutions/paul-ehrlich-institut/), [University Hospital Düsseldorf / CIO Düsseldorf](https://onco.cc/institutions/uk-duesseldorf/)
- bottlenecks: [The brain: barrier and sanctuary](https://onco.cc/bottlenecks/b-brain-delivery/)
- ideas: [A university cyclotron network with shared regulatory files for new tracers](https://onco.cc/ideas/idea-fund-academic-radiopharma-pipeline/), [Core-funded radiotherapy trials infrastructure with central quality assurance](https://onco.cc/ideas/idea-fund-radiotherapy-trials-infrastructure/)
- key papers: [First trial of a vaccine against the shared neoantigens of mismatch-repair-deficient cancers](https://onco.cc/key-papers/paper-lynch-frameshift-vaccine-ccr-2020/), [Heining 2018: NRG1 fusions in KRAS wild-type pancreatic cancer](https://onco.cc/key-papers/paper-heining-nrg1-fusions-kras-wild-type-pancreatic-cancer-discov-2018/)
- trials: [NOA-08](https://onco.cc/trials/noa-08/)

---
JSON: https://onco.cc/api/v1/entities/heidelberg-nct.json